When patients were segregated into cohorts according to intrinsic tumor subtypes, we found that high MMP3 expression was significantly associated with poor DMFS for patients with luminal A subtype tumors (Figure 3C, N=918; HR=1.6 [95% CI 1.18-2.17], p=0. This evidence concerns the gene MMP3 and neoplasm.